# The Role of Butirprost® in Combination With Antibiotics in Chronic Bacterial Prostatitis (CBP) Treatment

> **NCT06684626** · PHASE3 · COMPLETED · sponsor: **Federico II University** · enrollment: 60 (actual)

## Conditions studied

- Prostate Inflammation
- Prostate Disease
- Chronic Bacterial Prostatitis

## Interventions

- **DRUG:** Sodium Hyaluronate
- **DRUG:** Levofloxacin 500mg

## Key facts

- **NCT ID:** NCT06684626
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-01
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-09-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06684626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06684626, "The Role of Butirprost® in Combination With Antibiotics in Chronic Bacterial Prostatitis (CBP) Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06684626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*